Reviva Pharmaceuticals (RVPH) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.44
-0.37
-0.31
-0.24

Details

Expected EPS
-0.244
Actual EPS
-0.25
Surprise EPS
-0.01
Surprise Percent
+2.46%

Description

Reviva Pharmaceuticals (RVPH) has reported earnings of -0.25 per share for Q4 2024.

0 Comments

Share your thoughts